Mitophagy in metabolic syndrome
Abstract Metabolic syndrome (MS), a chronic and non‐communicable pathological condition, is characterized by a constellation of clinical manifestations including insulin resistance, abdominal adiposity, elevated blood pressure, and perturbations in lipid metabolism. The prevalence of MS has increase...
Main Authors: | Mei‐Qi Miao, Yu‐Bo Han, Li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14650 |
Similar Items
-
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
by: Zuqing Su, et al.
Published: (2019-10-01) -
The role of mitophagy in metabolic diseases and its exercise intervention
by: Shaokai Tang, et al.
Published: (2024-01-01) -
Mitophagy: A potential therapeutic target for insulin resistance
by: Peng Ning, et al.
Published: (2022-08-01) -
Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders
by: Zuqing Su, et al.
Published: (2021-08-01) -
Identification of Mitophagy-Associated Genes for the Prediction of Metabolic Dysfunction-Associated Steatohepatitis Based on Interpretable Machine Learning Models
by: Deng B, et al.
Published: (2024-05-01)